Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2010

View Archived Issues

BSAM-2/Alhydrogel/CPG-7909 vaccine enters clinical evaluation in malaria-naive adults

Phase I data support safety and preliminary activity of MLTA3698A in active RA

PET tracer [11C]-NS-14492 can visualize in vivo occupancy of nicotinic acetylcholine alpha7 receptor

Mitsubishi Tanabe Pharma reports highlights of second quarter fiscal year 2010

Roche reports on third quarter of 2010

FDA advisory committee recommends approval of Benlysta for SLE

Switch pocket kinase inhibitors DP-4610, DP-3556 and DP-4178 show promise in models of RA

Typhoid fever vaccine Vi-TT is safe in pediatric and juvenile subjects

Vectura presents phase II data on VR-040 in Parkinson's disease

New tyrosine protein kinase inhibitor-oligomer conjugates claimed

Allozyne reports proof-of-concept data on AZ-17

New inhibitors of alpha-amylase 1 and lysosomal alpha-glucosidase patented

Clinuvel receives Australian orphan drug status for Scenesse in EPP and CEP

New modulators of retinol-binding protein 4 presented by IRM

Takeda patents new modulators of retinol binding protein 4

Juvenile Diabetes Research Foundation and Amylin Pharma partner on metreleptin

Cardio3 BioSciences reports on phase II C-Cure trial in heart failure

Banyu Pharma describes new agonists of bile acid GPBA receptor

Anthera Pharma places voluntary hold on PEARL-SC trial

Orally disintegrating imidafenacin tablet approved in Japan for overactive bladder

EMA accepts Pixuvri MAA for non-Hodgkin's lymphoma for review

Intercell reports phase II data on V-710 vaccine in end-stage renal disease

FDA advisory committee recommends approval of Merck & Co.'s sBLA for Gardasil

Encouraging interim data reported from phase IIb TMC-435 trial in hepatitis C

EMA's COMP recommends orphan status for paquinimod in systemic sclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...